FDA Commissioner Faces Pressure To Limit Abortion Pill After Study Finds Increased Risks

Dr. Martin Makary, FDA CommissionerThis isn’t the first time Makary has encountered questions about the status of mifepristone under his leadership.

Komentar

Postingan populer dari blog ini